FDA Webview
X
about-us-banner

FDA Related News

Home / Articles / FDA Related News
latest-news-card-1
Medical Devices

Tempus AI Device for Atrial Fibrillation

FDA clears a Tempus AI 510(k) for its Tempus ECG-AF device that uses artificial intelligence to help identify patients at increased risk of atrial fib...

Medical Devices

Fujifilm New CT System Cleared

FDA clears a Fujifilm Healthcare Americas 510(k) for its new compact, 128-slice computed tomography (CT) system, the FCT iStream.

latest-news-card-1
FDA General

Public Citizen Ideas to Improve Advisory Committees

Public Citizen recommends three steps FDA should take to improve the public perception and understanding of the work of agency advisory committees.

latest-news-card-1
Human Drugs

14 Submissions with RWE in FY 2023: FDA

FDA publishes a table with information on 14 drug submissions in FY 2023 that contained real-world evidence.

Animal Drugs

PZAD Designation, Review Process Guidance

FDA publishes a guidance to help sponsors pursue Priority Zoonotic Animal Drug designation for a new animal drug.

latest-news-card-1
Human Drugs

Guidance on Study Underrepresentation Diversity Plans

FDA publishes a draft guidance on the content and format of certain diversity action plans intended to increase clinical study enrollment of participa...

latest-news-card-1
Human Drugs

Verona Gets Ohtuvayre Approval for COPD

FDA approves a Verona Pharma NDA for Ohtuvayre (ensifentrine) for the maintenance treatment of chronic obstructive pulmonary disease (COPD) in adult p...

latest-news-card-1
Human Drugs

BrainStorm Gets FDA Alignment on CMC Issues

BrainStorm Cell Therapeutics says it has reached alignment with FDA on chemistry, manufacturing, and controls aspects of the companys upcoming Phase 3...

latest-news-card-1
Human Drugs

2nd Complete Response on AbbVie Parkinsons Drug

FDA sends AbbVie a second complete response letter on its NDA for ABBV-951 (for carbidopa/foslevodopa) for treating motor fluctuations in adults with ...

latest-news-card-1
Federal Register

Guide on Lab-Developed Test Compliance Guide

Federal Register notice: FDA makes available a final guidance entitled Laboratory Developed Tests (LDTs): Small Entity Compliance Guide.